# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-13-050235
Filing Date
2013-09-11
Accepted
2013-09-11 16:23:35
Documents
34
Period of Report
2013-09-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | v354822_8k.htm | 8-K | 18350
2 | EXHIBIT 99.1 | v354822_ex99-1.htm | EX-99.1 | 11590
3 | EXHIBIT 99.2 | v354822_ex99-2.htm | EX-99.2 | 41881
4 | GRAPHIC | ex99x2_001.jpg | GRAPHIC | 39721
5 | GRAPHIC | ex99x2_002.jpg | GRAPHIC | 104408
6 | GRAPHIC | ex99x2_003.jpg | GRAPHIC | 86748
7 | GRAPHIC | ex99x2_004.jpg | GRAPHIC | 57851
8 | GRAPHIC | ex99x2_005.jpg | GRAPHIC | 67220
9 | GRAPHIC | ex99x2_006.jpg | GRAPHIC | 22822
10 | GRAPHIC | ex99x2_007.jpg | GRAPHIC | 63156
11 | GRAPHIC | ex99x2_008.jpg | GRAPHIC | 72200
12 | GRAPHIC | ex99x2_009.jpg | GRAPHIC | 75674
13 | GRAPHIC | ex99x2_010.jpg | GRAPHIC | 63806
14 | GRAPHIC | ex99x2_011.jpg | GRAPHIC | 71577
15 | GRAPHIC | ex99x2_012.jpg | GRAPHIC | 58743
16 | GRAPHIC | ex99x2_013.jpg | GRAPHIC | 91077
17 | GRAPHIC | ex99x2_014.jpg | GRAPHIC | 22468
18 | GRAPHIC | ex99x2_015.jpg | GRAPHIC | 59974
19 | GRAPHIC | ex99x2_016.jpg | GRAPHIC | 68260
20 | GRAPHIC | ex99x2_017.jpg | GRAPHIC | 48320
21 | GRAPHIC | ex99x2_018.jpg | GRAPHIC | 57664
22 | GRAPHIC | ex99x2_019.jpg | GRAPHIC | 69395
23 | GRAPHIC | ex99x2_020.jpg | GRAPHIC | 22081
24 | GRAPHIC | ex99x2_021.jpg | GRAPHIC | 69572
25 | GRAPHIC | ex99x2_022.jpg | GRAPHIC | 81065
26 | GRAPHIC | ex99x2_023.jpg | GRAPHIC | 69923
27 | GRAPHIC | ex99x2_024.jpg | GRAPHIC | 67819
28 | GRAPHIC | ex99x2_025.jpg | GRAPHIC | 70121
29 | GRAPHIC | ex99x2_026.jpg | GRAPHIC | 78875
30 | GRAPHIC | ex99x2_027.jpg | GRAPHIC | 24736
31 | GRAPHIC | ex99x2_028.jpg | GRAPHIC | 40584
32 | GRAPHIC | ex99x2_029.jpg | GRAPHIC | 39056
33 | GRAPHIC | ex99x2_030.jpg | GRAPHIC | 63111
34 | GRAPHIC | image_032.jpg | GRAPHIC | 4281
| Complete submission text file | 0001144204-13-050235.txt |  | 2602141

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 131091284
SIC: 2836 Biological Products, (No Diagnostic Substances)